Cargando…

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

SIMPLE SUMMARY: Myeloid-derived suppressive cells (MDSCs) are important for the progression of human tumors and represent potential targets for novel therapeutic strategies in breast and other cancers. To develop such strategies, pre-clinical models mimicking patient tumors are needed. In this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gjerstorff, Morten F., Traynor, Sofie, Gammelgaard, Odd L., Johansen, Simone, Pedersen, Christina B., Ditzel, Henrik J., Terp, Mikkel G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9777315/ https://www.ncbi.nlm.nih.gov/pubmed/36551639 http://dx.doi.org/10.3390/cancers14246153

Ejemplares similares

Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes
por: Terp, Mikkel G., et al.
Publicado: (2021)

ZBED1 Regulates Genes Important for Multiple Biological Processes of the Placenta
por: Johansen, Simone, et al.
Publicado: (2022)

SSX addiction in melanoma propagates tumor growth and metastasis
por: Traynor, Sofie, et al.
Publicado: (2022)

Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins
por: Traynor, Sofie, et al.
Publicado: (2019)

Human cancer evolution in the context of a human immune system in mice
por: Gammelgaard, Odd L., et al.
Publicado: (2018)

Human DREF/ZBED1 is a nuclear protein widely expressed in multiple cell types derived from all three primary germ layers
por: Hansen, Simone Valentin, et al.
Publicado: (2018)

The Cancer/Testis Antigen Gene VCX2 Is Rarely Expressed in Malignancies but Can Be Epigenetically Activated Using DNA Methyltransferase and Histone Deacetylase Inhibitors
por: Jakobsen, Mie K., et al.
Publicado: (2021)

The role of GAGE cancer/testis antigen in metastasis: the jury is still out
por: Gjerstorff, Morten Frier, et al.
Publicado: (2016)

HMGA2 Supports Cancer Hallmarks in Triple-Negative Breast Cancer
por: Mansoori, Behzad, et al.
Publicado: (2021)

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity
por: Gammelgaard, Odd L, et al.
Publicado: (2022)

Epigenetic targeting of myeloid-derived suppressor cells: time to move into infectious diseases?
por: Gjerstorff, Morten Frier
Publicado: (2023)

A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence
por: Brückmann, Nadine H., et al.
Publicado: (2019)

Lack of ADAM2, CALR3 and SAGE1 Cancer/Testis Antigen Expression in Lung and Breast Cancer
por: Maheswaran, Emeaga, et al.
Publicado: (2015)

Publisher Correction: Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
por: Alves, Carla L., et al.
Publicado: (2021)

Oncogenic cancer/testis antigens: prime candidates for immunotherapy
por: Gjerstorff, Morten F., et al.
Publicado: (2015)

Interaction between Polycomb and SSX Proteins in Pericentromeric Heterochromatin Function and Its Implication in Cancer
por: Johansen, Simone, et al.
Publicado: (2020)

Analysis of GAGE, NY-ESO-1 and SP17 cancer/testis antigen expression in early stage non-small cell lung carcinoma
por: Gjerstorff, Morten F, et al.
Publicado: (2013)

PDX: Moving Beyond Drug Screening to Versatile Models for Research Discovery
por: Risbridger, Gail P, et al.
Publicado: (2020)

PNA-Pdx: Versatile Peptide Nucleic Acid-Based Detection of Nucleic Acids and SNPs
por: Jiang, Wenjun, et al.
Publicado: (2023)

Novel monoclonal antibodies against Pdx1 reveal feedback regulation of Pdx1 protein levels
por: Galbo, T., et al.
Publicado: (2010)

Restriction of GAGE protein expression to subpopulations of cancer cells is independent of genotype and may limit the use of GAGE proteins as targets for cancer immunotherapy
por: Gjerstorff, M F, et al.
Publicado: (2006)

Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER‐positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor
por: Karimi, Leena, et al.
Publicado: (2023)

The role of myeloid derived suppressor cells in musculoskeletal disorders
por: Ren, Yi, et al.
Publicado: (2023)

HMGA2 as a Critical Regulator in Cancer Development
por: Mansoori, Behzad, et al.
Publicado: (2021)

KDM4B-regulated unfolded protein response as a therapeutic vulnerability in PTEN-deficient breast cancer
por: Wang, Wenyu, et al.
Publicado: (2018)

Decoding the Myeloid-Derived Suppressor Cells in Lymphoid Malignancies
por: Papafragkos, Iosif, et al.
Publicado: (2021)

Myeloid Derived Suppressor Cells in Chronic Myeloid Leukemia
por: Giallongo, Cesarina, et al.
Publicado: (2015)

GAGE Cancer-Germline Antigens Are Recruited to the Nuclear Envelope by Germ Cell-Less (GCL)
por: Gjerstorff, Morten F., et al.
Publicado: (2012)

Myeloid-Derived Suppressor Cells in Sepsis
por: Lai, Dengming, et al.
Publicado: (2014)

Myeloid-Derived Suppressor Cells in Sepsis
por: Schrijver, Irene T., et al.
Publicado: (2019)

On the origin of myeloid-derived suppressor cells
por: Millrud, Camilla Rydberg, et al.
Publicado: (2016)

Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016)

Pyridoxal phosphate synthases PdxS/PdxT are required for Actinobacillus pleuropneumoniae viability, stress tolerance and virulence
por: Xie, Fang, et al.
Publicado: (2017)

Solution Structures and Dynamic Assembly of the 24-Meric Plasmodial Pdx1–Pdx2 Complex
por: Ullah, Najeeb, et al.
Publicado: (2020)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

Replication and ribosomal stress induced by targeting pyrimidine synthesis and cellular checkpoints suppress p53-deficient tumors
por: Hubackova, Sona, et al.
Publicado: (2020)

Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013)

Myeloid-derived suppressor cells, age and cancer
por: Bowdish, Dawn ME
Publicado: (2013)

Chemotherapeutic targeting of myeloid-derived suppressor cells
por: Alizadeh, Darya, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_lmeqijm6f0gicrs8gdedgd5inc